Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
Chair of Translational Neuro-Oncology at the University of Manchester, previously a member of the Company’s Scientific Advisory Board, elected at the 2026 Annual General Meeting VANCOUVER, British Columbia, Sept. 10, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery,…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.